Catheter Precision, Inc. (VTAK) Stock Price

VTAKStock

$0.98−96.81%52W

Market Cap$1.86M

P/E—

PEG Ratio—

Div yield—

Beta-1.14

VTAK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-102.47%

Price vs S&P 500 (4W)-41.92%

VGM Score54.07

Book Value / Share (Quarterly)$4.87

P/TBV (Annual)0.28x

Revenue Growth (3Y)288.20%

Cash Flow / Share (Quarterly)$-2.66

Price vs S&P 500 (YTD)-107.34%

Gross Margin (TTM)47.73%

Net Profit Margin (TTM)-679.11%

EPS (TTM)$-7.07

10-Day Avg Trading Volume2.15M

EPS Excl Extra (TTM)$-7.07

Revenue Growth (5Y)25.89%

EPS (Annual)$-15.90

ROI (Annual)-160.02%

Gross Margin (Annual)92.31%

Net Profit Margin (5Y Avg)-65574.92%

Cash / Share (Quarterly)$0.51

Revenue Growth QoQ (YoY)380.66%

ROA (Last FY)-108.34%

Revenue Growth TTM (YoY)219.17%

EBITD / Share (TTM)$-10.14

ROE (5Y Avg)-238.31%

Operating Margin (TTM)-1150.76%

Cash Flow / Share (Annual)$-4.85

P/B Ratio0.17x

P/B Ratio (Quarterly)0.13x

Net Income / Employee (Annual)$-1,010,800

EV / Revenue (TTM)6.94x

Net Interest Coverage (TTM)-23.05x

ROA (TTM)-45.92%

EPS Incl Extra (Annual)$-15.90

Current Ratio (Annual)0.10x

Quick Ratio (Quarterly)0.15x

3-Month Avg Trading Volume1.02M

52-Week Price Return-96.81%

Revenue / Employee (TTM)$112,600

Tangible BV / Share (Quarterly)$0.06

P/S Ratio (Annual)3.55x

Asset Turnover (Annual)0.05x

52-Week High$30.60

Operating Margin (5Y Avg)-67948.18%

EPS Excl Extra (Annual)$-15.90

CapEx CAGR (5Y)-13.08%

26-Week Price Return-92.57%

Quick Ratio (Annual)0.06x

13-Week Price Return-85.08%

Total Debt / Equity (Annual)0.52x

Current Ratio (Quarterly)0.19x

Enterprise Value$13.29M

Revenue / Share Growth (5Y)-36.98%

Asset Turnover (TTM)0.07x

Revenue / Employee (Annual)$48,200

Inventory Turnover (Annual)1.06x

Pretax Margin (Annual)-2381.56%

Cash / Share (Annual)$0.05

3-Month Return Std Dev144.78%

Gross Margin (5Y Avg)-1553.08%

Net Income / Employee (TTM)$-765,000

ROE (Last FY)-243.53%

Net Interest Coverage (Annual)-11.01x

EPS Basic Excl Extra (Annual)$-15.90

Receivables Turnover (TTM)16.30x

Total Debt / Equity (Quarterly)0.63x

EPS Incl Extra (TTM)$-7.07

Receivables Turnover (Annual)7.28x

ROI (TTM)-78.41%

P/S Ratio (TTM)1.52x

Pretax Margin (5Y Avg)-67465.94%

Revenue / Share (Annual)$0.76

Tangible BV / Share (Annual)$4.29

Price vs S&P 500 (52W)-112.34%

Year-to-Date Return-95.41%

5-Day Price Return-16.00%

EPS Normalized (Annual)$-15.90

ROA (5Y Avg)-135.32%

Net Profit Margin (Annual)-2098.05%

Month-to-Date Return-44.00%

Cash Flow / Share (TTM)$-52.23

EBITD / Share (Annual)$-20.73

Operating Margin (Annual)-2979.61%

LT Debt / Equity (Annual)0.44x

ROI (5Y Avg)-217.50%

LT Debt / Equity (Quarterly)0.19x

EPS Basic Excl Extra (TTM)$-7.07

P/TBV (Quarterly)8.67x

P/B Ratio (Annual)0.43x

Inventory Turnover (TTM)14.72x

Pretax Margin (TTM)-721.20%

Book Value / Share (Annual)$4.06

Price vs S&P 500 (13W)-87.77%

Beta-1.14x

Revenue / Share (TTM)$0.69

ROE (TTM)-126.98%

52-Week Low$0.82

vGradeB

gGradeA

mGradeF

vgmGradeC

VTAK Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q3 2024	Nov 14, 2024	—	-$381.91	—
Q2 2024	Aug 14, 2024	-$49.40	-$1058.33	-2042.31%(-$1008.93)
Q1 2024	May 6, 2024	-$79.80	-$684.02	-757.14%(-$604.22)

VTAK Analyst Recommendations

Jun 2025

Jul 2025

Aug 2025

Oct 2025

4.29

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
VTAKCatheter Precision, Inc.	B	A	F	1.5x	25.9%	47.7%	-1150.8%	$0.98
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Catheter Precision, Inc.

Cathay Precision Inc is a medical device company specializing in cardiac electrophysiology solutions. Its lead product, the VIVO System, is a non-invasive 3D cardiac mapping platform for identifying ventricular arrhythmia origins prior to EP procedures and holds CE Mark approval for European commercialization. The company is expanding its product portfolio with LockeT, a surgical suture retention device designed to improve wound healing outcomes.